Hire the Best Nanotechnology Specialists in London, UK

With 9+ years of experience in plastics industry across consumer, medical and automotive sectors (BD, Avient), I combine deep polymer science knowledge with advanced tools to help organisations (large and small) struggling with Plastics R&D to solve their most complex problems. From Materials selection, toxicity analysis to handling supplier change to production issues, I can provide consultation and hands-on work to get your job done in the shortest time frame. Knows cradle-to-cradle development of plastics with strong knowledge in regulatory and legal requirements. Complete ownership and accountability, whether its root-cause analysis or innovation R&D Proven track record of translating challenging projects from TRL 3 to scale-up and full fledged production. Experienced in using advanced Machine learning tools for materials science engineering and proven record of success.

I am a Scientific Medical Consultant & Research Writer (PhD Biomedical Science) with extensive expertise in areas related to Pharmaceutical Sciences, Chemistry, Biology, and Health. Former Lecturer & Research Positions: University of Cambridge (UK) The National Institute of Genetics (Japan) University of North Carolina (USA) University of New South Wales (Australia) My clients usually hire me to provide leadership and insights into scientific challenges, commercial validation/development of products, funding applications, as well as ghost writing and assistance with publications in scientific peer review journals, academic papers and theses. From researching viable pharmaceutical preventions and treatments on COVID-19 (current work), to investigating paranormal activity and extraterrestrial life I am an excellent candidate to deliver your projects timely and to your complete satisfaction. Some of my clients include: Massachusetts Institute of Technology, USA Oxford University, UK JC BioSciences, CA, USA Sports Surgery Clinic, Dublin, Ireland ABM Publishing, China Beijing Hospital of Traditional Chinese Medicine, China MedInsight Research Institute, UK/Israel University of Auckland, New Zealand Positive Client Feedback: "[Vyacheslav’s] medical and scientific knowledge is matched by an exceptional ability to make complex topics clear and easy to understand. His scientific analysis has commercial application without any need to simplify or translate it into commercial terminology." "Excellent. Delivered exactly what was requested and was able to analyze the specifics for me and summarize it for me and understand the complex medical terminology. Went above and beyond- he was the first person I picked and lucked out. Very happy and highly recommend. He also is a caring person- not just a dry academic." Scientific Peer-Review Publications: I have publications in 50+ renowned scientific peer-reviewed journals such as Journal of Biological Chemistry, Journal of American Chemical Society, Journal of Pharmacy and Pharmacology, Angewandte Chemie International Edition, and Nucleic Acids Research, to name a few. Specific Areas of Expertise: Research into aging Cancer research Neuroscience Nutrition science / dietetics / supplements Sport Medicine DNA Biotechnology Organic and synthetic chemistry Bioorganic chemistry Medicinal chemistry Molecular biology Molecular genetics Virology Molecular mechanisms of evolution Molecular mechanisms of diseases New drug development and design Pharmaceutical research

I am a Professor in Chemistry at Queen Mary University of London, where I lead a research group specialising in nanotherapeutics, nanotechnology, polymer-based synthetic cells, and biotechnology. I combine academic leadership with hands-on entrepreneurial and industry experience, including founding Hemolytics, a spin-out company focused on advanced haemocompatibility testing and safety analytics for nanomedicine and biotherapeutic platforms. I also contributed to QwikZyme, a rapid SARS-CoV-2 diagnostic developed during my time at Imperial College London, which formed the basis of a separate commercialisation effort in point-of-care diagnostics. In addition to my academic work, I serve as a consultant for companies in nanotherapeutics, nanotechnology and biotechnology, supporting R&D strategy, nanoparticle design, haemocompatibility assessment, assay development, and early-stage technology translation. I help clients move from concept to prototype, strengthen IP, and prepare technical materials, grant applications and due-diligence documentation. Strengths & Skills: - Nanotherapeutics, nanoparticle design, LNPs, liposomes, polymersomes & synthetic cells - Haemocompatibility, haemolysis testing, safety evaluation of nanomaterials - Biotechnology, diagnostics, rapid assay development - Polymer chemistry, soft matter, controlled radical polymerisation - Commercialisation, spin-out development, translation & IP strategy - High-quality technical writing, grant writing, and scientific problem-solving I bring a combination of academic rigour, entrepreneurial experience, and industry focus, supported by high-impact publications, patents, and collaborations across the UK, Europe and the US. I help clients accelerate innovation through clear communication, deep technical expertise, and solutions tailored to real-world application.

I am a seasoned scientist with experience across the fields of chemical biology and drug discovery. The basis of my science is organic chemistry and I have spent several years performing structure guided design and synthesis of molecules for drug discovery. This experience is augmented with a wide variety of biochemistry, biophysics and molecular biology techniques. Past Research Work During my postdoctoral work at Imperial College in the group of Prof. Ed Tate, I worked on a drug discovery project involving a transmembrane enzyme. I led a small team from high throughput screen output to a candidate with in-vivo applicability. This included hit confirmation and selection, structure guided compound design, performing and optimising biochemical assays, setting up and performing cellular assays and PK studies up to in vivo dosing. This work also included me spearheading the development our cellular assay kit using CRISPR/Cas gene editing. I have also successfully raised >300k worth of academic research funding for this project. In my PhD I studied molecular glues for 14-3-3 protein-protein interactions in the group of Prof Christian Ottmann and Prof. Luc Brunsveld. This work included design and synthesis of novel molecular glue compounds. I wanted to expand my activities in this area to include semi-synthesis on a class of natural products call Fusicoccins. This led me to perform a secondment in the group of Prof. Nobuo Kato at Osaka University, the absolute leader in the field. To study the effect of my compounds, I expanded my skillset to include a broad range of assays such as FP, SPR, ITC, MST and X-ray crystallography. I managed to generate and characterise the most potent 14-3-3 molecular glue reported to date, and set up a method to characterise three body binding events such as a molecular glue and two proteins. Current Research Work I am currently setting up a completely new research project from scratch in the field of metabolic oligosaccheride engineering applied to wastewater treatment. This is a challenging project with real world application in which I am attempting to unravel the function of sialic acids in aerobic granular sludge wastewater treatment plants. This involves the synthesis glycan probes for metabolic labelling and applying this methodology to the extracellular polymeric substance of Candidatus Accumulibacter cultures in liter scale bioreactors.